Chromate reduction at low sulphate concentration in hydrogen-fed bioreactors.

Aimed at developing a bioremediation process to treat Cr(VI)-bearing water at low sulphate concentration in order to reduce excess sulphide production, the highly toxic, mutagenic, and soluble Cr(VI) was reduced to the less toxic and insoluble Cr(III) in 2-litre fixed-bed reactors inoculated with the sulphate-reducing bacterium (SRB) Desulfomicrobium norvegicum, capable of performing direct enzymatic Cr(VI) reduction. H2 was used as the electron source. The fixed-films were developed on three different supports: a PVC cross-flow material, a pozzolana, and a ceramic granulate. The phased experiments began with a progressive increase of the Cr(VI) concentration in the feed to the column reactors, followed by a progressive decrease of the sulphate concentration. Inhibition by Cr(VI) was less pronounced with pozzolana than with the other supports; when the pozzolana column was fed with a medium containing 100 mg l(-1) Cr(VI) and only 250 mg l(-1) sulphate, the lowest residence time that could be applied for complete Cr(VI) reduction was 16 h. The molar ratio between the sulphate and Cr(VI) reduction rates was decreased down to 1.5, suggesting that indirect reaction with HS was not the sole mechanism of Cr(VI) reduction.

Reduction of chromate by fixed films of sulfate-reducing bacteria using hydrogen as an electron source.

The ability of sulfate-reducing bacteria (SRB) to reduce chromate, Cr(VI), was evaluated using fixed-film growth systems and H2 as the electron source. A main objective of the experiment was to distinguish between direct enzymatic reduction and indirect reduction by hydrogen sulfide, in order to subsequently verify and control the synergy of these two mechanisms. In batch experiments with the sulfate-reducing consortium CH10 selected from a mining site, 50 mg l(-1) Cr(VI) was reduced in 15 min in the presence of 500 mg l(-1) hydrogen sulfide compared to 16 mg l(-1) reduced in 1 h without hydrogen sulfide. Fixed films of a CH10 population and Desulfomicrobium norvegicum were fed-batch grown in a column bioreactor. After development of the biofilm, hydrogen sulfide was removed and the column was fed continuously with a 13-mg l(-1) Cr(VI) solution. Specific Cr(VI) reduction rates on pozzolana were close to 90 mg Cr(VI) h(-1) per gram of protein. Exposure to Cr(VI) had a negative effect on the subsequent ability of CH10 to reduce sulfate, but the inhibited bacteria remained viable.

Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking.

The level of (+/-)-r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene (anti-BPDE) bound to DNA of lymphocytes plus monocytes in 39 coke oven workers exposed to polycyclic aromatic hydrocarbons (PAH) and 39 non-exposed persons (controls) were investigated, each of the groups consisting of smokers and non-smokers. The adduct level was measured by an improved HPLC/fluorescence method (Rojas, M., Alexandrov, K., van Schooten, F. J., Hillebrand, M., Kriek, E. and Bartsch, H., Carcinogenesis, 15, 557-560, 1994) through the release of the corresponding benzo[a]pyrene (B[a]P) tetrols. The anti-BPDE-DNA adduct was detected in 51% of coke oven workers exposed to PAH and in 18% of the non-exposed (control) subjects. The mean level of anti-BPDE-DNA adducts/10(8) nucleotides in coke oven workers (15.7 +/- 37.8) was approximately 8 times higher than in non-exposed subjects (2.0 +/- 8.7). The interindividual variation of adduct levels was approximately 100-fold in coke oven workers and approximately 50-fold in controls respectively. Smokers in the exposed group had 3.5 times more DNA adducts than non-smokers. With the exception of one non-smoker with very high adduct levels (52.8 adducts/10(8)), the control subjects showed the presence of barely detectable adducts in only 16% of the samples examined. The increased in vivo formation in some smokers and high variability of anti-BPDE-DNA adducts in coke oven workers suggests variations in genetically controlled activation/inactivation reactions of PAH metabolism.